Aesthetic Medical International Holdings Group Capital Expenditures (CapEx) Growth & History (PAIYY)
Aesthetic Medical International Holdings Group's capital expenditures (capex) was ¥7.0M for fiscal 2025.
View full Aesthetic Medical International Holdings Group company overviewAesthetic Medical International Holdings Group annual capital expenditures (capex) history
| Fiscal year | Period ended | Capital expenditures (CapEx) | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | ¥7.0M | −¥23.6M | −77.19% |
| 2024 | 2024-12-31 | ¥30.6M | −¥24.6M | −44.61% |
| 2023 | 2023-12-31 | ¥55.2M | ¥53.6M | +3359.24% |
| 2022 | 2022-12-31 | ¥1.6M | −¥31.6M | −95.20% |
| 2021 | 2021-12-31 | ¥33.2M | −¥5.1M | −13.34% |
| 2020 | 2020-12-31 | ¥38.4M | −¥30.8M | −44.50% |
| 2019 | 2019-12-31 | ¥69.1M | ¥23.6M | +51.84% |
| 2018 | 2018-12-31 | ¥45.5M | −¥2.0M | −4.17% |
| 2017 | 2017-12-31 | ¥47.5M | — | — |
Aesthetic Medical International Holdings Group capital expenditures (capex) trends
Over the last five fiscal years, Aesthetic Medical International Holdings Group's capital expenditures (capex) decreased from ¥38.4M to ¥7.0M, a change of −¥31.4M.
What capital expenditures (CapEx) mean
Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.
SEC-reported capital expenditures
TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Aesthetic Medical International Holdings Group source filings ↗